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Abstract: Objective: It has been reported that surgical treatment for prosthetic valve endocarditis 
complicated with destruction of the aortic annulus is associated with high mortality and morbidity. We 
use a relatively simple procedure consisting of a patch plasty of the abscess cavity, in addition to 
complete removal of the infected tissue of the abscess cavity followed by a standard aortic valve 
replacement. 
Methods: Between October 2003 and April 2009, 8 patients (7 males; mean age, 68.6 ± 9.8 years) with 
prosthetic valve endocarditis complicated with destruction of the aortic annulus were surgically 
treated at Tominaga hospital. All patients were in New York Heart Association functional class III or IV. 
All patients had active endocarditis. Preoperative echocardiography revealed that 4 patients had 
moderate or severe aortic regurgitation, and 2 patients had mitral valve endocarditis as well. 
Results: There were no operative deaths (≤30 days). Cardiac complications included paroxysmal atrial 
fibrillation in 3 patients and transient atrioventricular block in one. One patient died of multiple organ 
failure 66 days after the surgery. The overall in-hospital mortality was 12.5%. Patients were followed-
up for 6 to 49 months (mean, 31±19 months). There was no recurrent prosthetic valve endocarditis. 
One patient required reoperation (mitral annuloplasty and redo aortic valve replacement) mainly due 
to severe functional mitral regurgitation. There were 2 late deaths: lung cancer in 1 and multiple organ 
failure related to pneumonia after the aforementioned redo operation. 
Conclusion: Our simple procedure for complicated prosthetic valve endocarditis yielded excellent early 
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Abstract 
Objective: It has been reported that surgical treatment for prosthetic valve endocarditis 
complicated with destruction of the aortic annulus is associated with high mortality and 
morbidity. We use a relatively simple procedure consisting of a patch plasty of the 
abscess cavity, in addition to complete removal of the infected tissue of the abscess 
cavity followed by a standard aortic valve replacement. 
Methods: Between October 2003 and April 2009, 8 patients (7 males; mean age, 68.6 + 
9.8 years) with prosthetic valve endocarditis complicated with destruction of the aortic 
annulus were surgically treated at our hospital. All patients were in New York Heart 
Association functional class III or IV. All patients had active endocarditis. Preoperative 
echocardiography revealed that 4 patients had moderate or severe aortic regurgitation, 
and 2 patients had mitral valve endocarditis as well. 
Results: There were no operative deaths (<30 days). Cardiac complications included 
paroxysmal atrial fibrillation in 3 patients and transient atrioventricular block in one. 
One patient died of multiple organ failure 66 days after the surgery. The overall 
in-hospital mortality was 12.5%. Patients were followed-up for 6 to 49 months (mean, 
31±19 months). There was no recurrent prosthetic valve endocarditis. One patient 
required reoperation (mitral annuloplasty and redo aortic valve replacement) mainly due 
to severe functional mitral regurgitation. There were 2 late deaths: lung cancer in 1 and 
multiple organ failure related to pneumonia after the aforementioned redo operation. 
Conclusion: Our simple procedure for complicated prosthetic valve endocarditis 
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Introduction 
Prosthetic valve endocarditis (PVE) is a serious complication that can follow aortic 
valve replacement, and severe PVE often destroys the aortic annulus, leading to 
“aorto-left ventricular discontinuity.” Periannular abscesses occur in a significant 
number of PVE patients, occurring in 56% to 100% of affected patients.
1,2
 Moreover, 
when destruction of the aortic annulus is present in patients with PVE, hemodynamic 
instability can easily occur as a result of the uncontrollable septic state associated with 
abscess formation, perivalvular leakage, prosthetic valve malfunction or conduction 
disturbances. These patients require complex surgical interventions in addition to 
aggressive antibiotic therapy.
1,2
 Therefore, multiple surgical techniques have been 
proposed for complex reconstruction to improve mortality and morbidity in PVE 
patients with destruction of the aortic annulus. 
Previous studies have reported good outcomes with aortic root replacement using 
homografts, which are thought to be more resistant to bacterial or fungal infections than 
prosthetic valves.
3-9
 In Japan, the supply of homografts is very limited, and as an 
alternative approach, the Ross procedure has been performed in some institutions with 
excellent results.
9
 However, the Ross procedure is technically demanding and requires 
longer cross-clamp time and cardiopulmonary bypass time, potentially increasing 
mortality and morbidity.  
Since 2003, we have performed a relatively simple procedure for PVE complicated 
with destruction of the aortic annulus. Our technique includes patch reconstruction of 
the aortic annulus followed by placement of a new prosthetic valve in addition to 
aggressive removal of the infected tissue and drainage of the abscess cavity.   
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complicated with destruction of the aortic annulus. 
 
Patients and Methods 
Patients 
Between October 2003 and April 2009, 8 patients were admitted to Tominaga hospital 
with a diagnosis of PVE complicated with destruction of the aortic annulus. These 
patients formed the cohort for this study. In all of these patients, diagnosis was made 
based on the Duke criteria.
1,10
  
The patient demographics and clinical characteristics are summarized in Table 1. The 
mean age was 68.6 + 9.8 years (range, 53 to 84 years) and 7 patients were male. All 
patients were in New York Heart Association (NYHA) functional class III or IV and had 
active infection. The median interval between the initial and the redo operation was 5.5
±6.1 months (range of 1.9 to 20.3 months). In terms of the onset of infection11, there 
was 1 case of early PVE (onset within two months of the initial operation) and 7 cases 
of late PVE (onset more than 2 months after the initial operation). Two patients had had 
dental treatment within 1 month prior to the onset of the PVE episode.  
For the initial aortic valve replacement (AVR), isolated AVR was performed in 4 
patients and AVR with additional surgical procedures was performed in 4 (Table 1). A 
permanent pacemaker was implanted in patient 7 due to sick sinus syndrome and patient 
8 had a minor stroke after the operation, while the other patients had no postoperative 
complications.  
In terms of infectious agents, the microorganisms causing PVE were 
methicillin-resistant Staphylococcus epidermidis (MRSE) in 5 patients, 
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The preoperative echocardiographic data are shown in Table 1. Left ventricular 
function was relatively preserved in this cohort, with a mean left ventricular ejection 
fraction (LVEF) of 57 + 18%, although 2 patients had significantly depressed LVEF 
(25% and 35%). Visible vegetation on the aortic prosthesis was usually identified by 
either transthoracic or transesophageal echocardiography. Perivalvular leakage was 
common, with moderate or severe aortic regurgitation (AR) in 4 patients. Pressure 
gradients across the prosthetic valve were commonly elevated because of restricted 
mobility of leaflets and obstruction of left ventricular outflow due to the presence of 
abscesses formation. Two patients were found to have vegetation on the mitral valve as 
well.  
Indications for surgery were advancing congestive heart failure in 1 patient and 
uncontrollable infection despite aggressive antibiotic treatment in 7. 
 
Surgical Technique 
Surgery was performed via median sternotomy with the use of extracorporeal 
circulation and mild systemic hypothermia. Myocardial protection was accomplished by 
antegrade and, if feasible, retrograde cold blood cardioplegia. The left ventricle was 
vented by cannulation through the right superior pulmonary vein.  
Our surgical strategy for PVE complicated with destruction of the aortic annulus 
consisted of radical debridement (complete removal of infected or necrotic tissue with a 
curette) and irrigation of the abscess cavity with large amount of saline solution. Most 
times, patch reconstruction of the left ventricular outflow tract at the level of and below 
the aortic annulus was required using equine pericardium with a 5-0 polypropylene 
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injected into the cavity. When the aortic annulus was reconstructed, AVR was performed 
with pledgeted mattress sutures passed through both the patch and the aortic wall to 
securely anchor the prosthetic valve to the reconstructed aortic annulus. Sometimes, the 
sutures were passed from outside the aortic wall to pass through enough tissue to 
stabilize the prosthesis. Postoperatively, sufficient antibiotics were administered 
intravenously for at least 4 to 6 weeks, and then oral antibiotics were given for at least 
several months.  
 
Results 
Operative and Early Postoperative Results 
The operative results are shown in Table 2. There were no intraoperative nor operative 
deaths (<30 days). As shown in Figure 1, abscess cavities were found in the entire aortic 
annulus in 4 patients (this was classified as “aorto-left ventricular discontinuity”). None 
of these patients had any abscess formation beyond the sinus of Valsalva or near the 
coronary ostia. In 2 patients, direct closure of the cavity was feasible because the 
abscess cavity was small (only a 3-5mm gap was identified). AVR was performed using 
biological valves in 4 patients and mechanical valves in 4. Patient 6 had vegetation on 
both aortic and mitral prostheses, which necessitated redo mitral valve replacement 
using the standard technique. In patient 7, we removed vegetation attached to the native 
mitral valve in addition to AVR. 
All patients were successfully weaned from cardiopulmonary bypass, but 3 patients 
required an intra-aortic balloon pump to achieve hemodynamic stability. The mean 
cardiopulmonary bypass time was 213±82 minutes (range, 112 to 367 minutes), and 
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the patients left the operation room without significant aortic regurgitation (AR; defined 
as mild or less). 
As shown in Table 2, patient 8 developed multiple complications, including general 
prostration caused by infectious colitis, renal dysfunction and pneumonia, and 
eventually died of multiple organ failure 66 days after the operation. The overall 
in-hospital mortality rate was 12.5%. The median postoperative respiratory support time 
was 27 hours (range, 12 to 184 hours) and the mean hospital stay, excluding the one of 
hospital death, was 65±22 days (range, 34 to 92 days). During the hospital stays, 3 
patients developed paroxysmal atrial fibrillation and 1 patient developed transient 
atrioventricular block which did not required permanent pacemaker implantation. 
Patient 6 required sternal wound re-exploration for postoperative bleeding. Patient 7 had 
refractory gastrointestinal bleeding and also required prolonged respiratory support. No 
patients had recurrent infection on prosthetic valves or sepsis. Echocardiographic 
examination on discharge revealed that two patients had developed moderate AR. 
 
Mid-Term Follow-up Results 
Patients were followed up for 6 to 49 months, with a mean of 31±19 months. Patient 1 
was lost to follow-up at 8 months after surgery. Patient 2 required re-operation (mitral 
annuloplasty and redo AVR) mainly due to severe functional MR 32 months after the 
previous redo AVR. This was essentially associated with poor left ventricular function 
and a dilated left ventricle. Repeat AVR was also performed because this patient had 
moderate AR due to perivalvular leakage. Of note, there was no evidence of recurrent 
infection around the aortic root. This patient died of multiple organ failure related to 
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operation. 
Follow-up echocardiography demonstrated that 2 patients had moderate AR without 
hemodynamic instability. Four patients continue to be followed up at our institution and 
are in NYHA functional class I or II with no signs of recurrent PVE. 
 
Discussion 
PVE complicated with destruction of the aortic annulus is a potentially fatal 
complication of AVR. The surgical treatment of this condition is challenging, with 
operative mortality rates ranging from 7.3% to 33%.
1,2,12-14
 This high mortality is 
associated with preoperative hemodynamic deterioration due to uncontrolled sepsis 
from abscess formation, valve malfunction, multiple organ involvement due to severe 
infection and low cardiac output, and the complexity of the surgical procedure.
1,2
 
Because the surgical mortality rate of the third redo operation for recurrent PVE can be 
as high as 55.6%,
15
 it is very important to choose a surgical strategy that decreases the 
recurrence of PVE. 
The surgical management of PVE complicated with an aortic annular abscess 
involves aggressive and complete debridement of all infected or necrotic tissue, 
reconstruction of the damaged annulus and restoration of valve function. Many authors 
have reported that extended debridement and resection of infected paravalvular tissue 
are more important than the materials used for the reconstruction of the aortic 
valve.
7,17,18,20,21
 Despite the fact that aggressive debridement may cause complete heart 
block requiring permanent pacemaker implantation, debridement of all infected tissue 
remains the first priority.  
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mixed with antibiotics into the abscess cavity. We employed this technique whenever 
we performed patch reconstruction of the aortic annulus, because antibiotics mixed with 
fibrin glue are thought to be delivered continuously into the surrounding tissue for the 
first few days following surgery.
16
 There was no recurrence of PVE in our series, 
although this does not conclusively prove the effectiveness of this technique.  
Other surgical techniques that have been used in the past include valve replacement 
with patch closure of the abscess cavity,
17-19
 aortic root replacement using a 
homograft,
3-7







 and translocation of the aortic valve with saphenous vein 
bypass grafts to the coronary arteries.
23,24
  
It is well known that both homografts and autografts offer excellent hemodynamic 
performance and it is thought that they are resistant to infection. Indeed, the reported 
incidence of recurrent PVE after aortic root replacement using homografts or autografts 
range from 0% to 4.2% and 0% to 4%, respectively.
3-9
 However, persistent infection and 
false aneurysms or valve degeneration requiring reoperation can occur even after aortic 
root replacement using a homograft.
18,25
 Furthermore, the Ross procedure is technically 
demanding and increases aortic cross-clamp time and cardiopulmonary bypass time, and 
valve dysfunction can occur in both neo aortic valves (in the case of homografts) and 
neo pulmonary valve (in the case of homografts or other prostheses).
9
 Also, the 
longevity of homografts (either for AVR or for PVR in the Ross procedure) remains 
unclear, and younger patients may require reoperation at a later date due to structural 
valve deterioration. Repeat operation in patients with homografts can be very 
challenging because homografts tend to become heavily calcified.
26
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homografts, particularly for emergent or urgent situations. This is the reason we 
designed a relatively simple procedure that consists of reconstruction of the aortic 
annulus using equine pericardium followed by AVR in patients with PVE complicated 
with destruction of the aortic annulus. David et al. reported that there were no recurrent 
infections after AVR and patch plasty in patients with PVE and aortic root abscesses,
17
 
and Lytle et al. and d'Udekem et al. reported that standard AVR with pericardial patch 
reconstruction for PVE was not inferior to aortic root replacement using a 
homograft.
18,19
 Although we did not compare our procedure with any other surgical 
interventions, there were no cardiac-related deaths during hospitalization following our 
procedure. Moreover, since there was no recurrence of PVE during the mid-term 
follow-up period in our study, the recurrence rate may not be affected by the choice of 
the materials used for valve prostheses. Hagl et al. reported that the surgical outcome of 
aortic root replacement with a composite graft was superior to that of a homograft for 
PVE
20
, and Leyh et al. reported that the outcome of aortic root replacement using a 
composite graft was not inferior to that of a homograft.
21
 Moreover, several authors 
have recently reported good outcomes for AVR in patients with PVE and aortic root 
abscess using a Freestyle stentless valve.
9,13,22
 Since the handling qualities and 
performance of a Freestyle valve are similar to those of a homograft, they recommend 
the use of a Freestyle valve.
13,22
 A composite graft or Freestyle stentless valve can serve 
as a good alternative to a homograft for aortic root replacement. However, because 
prosthetic valve infection does not usually extend to the sinus of Valsalva or coronary 
ostium in most patients with PVE complicated with aortic root abscess,
2-9,12-15,17-25
 we 
do not believe that aortic root replacement is always necessary.  
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fragile annulus for stability. We anchored the valve with mattress sutures that were 
passed through both the patch and the aortic wall whenever we performed patch plasty 
of the aortic annulus. There were no postoperative complications due to valve 
dehiscence. Also, in early or mid-term follow-up, there were no re-reoperations, 
excluding one case who underwent mitral annuloplasty and redo AVR mainly due to 
severe functional mitral regurgitation. 
 
Conclusion 
Patients with PVE complicated with an aortic root abscess can be treated safely with 
patch reconstruction of the aortic annulus and AVR. The early and mid-term outcomes 
are satisfactory without any recurrence of endocarditis.  
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Figure legend 
Figure 1: Schemas of abscess cavity site (black shading) 
LCA: left coronary artery ostium; NCC: non coronary cusp; RCA: right coronary artery 
ostium 




















Indication for operation 
1 M 68 IV AVR (Mosaic23), CABG Unknown 25  III No Worsening CHF 
2 M 76 III AVR (CEP23) MRSE 74  III No Uncontrollable infection 
3 M 74 III AVR (CEP23) MRSE 70   I No Uncontrollable infection 
4 M 53 III AVR (CEP27) MSSE 59   I No Uncontrollable infection, 
peripheral emboli 
5 M 63 III AVR (CEP25), CABG MRSE 56  IV No Uncontrollable infection, 
severe AR 
6 M 60 IV AVR (SJM23), MVR (CM31), 
TAP, MAZE 
MRSE 65  III Yes Uncontrolable infection 
7 M 71 IV AVR(CEP25), MAP, TAP, 
MAZE 
MRSE 35   I Yes Uncontrollable infection 
8 F 84 IV AVR (Magna19) Unknown 68   II No Uncontrollable infection 
AR: aortic regurgitation; AVR: aortic valve replacement; CABG: coronary artery bypass grafting; CEP: Carpentier-Edwards Pericardial; CHF: congestive 
heart failure; CM: CarboMedics; LVEF: left ventricular ejection fraction; MAP: mitral annloplasty; MRSE: methicillin-resistant Staphylococcus 























1 Yes No Mosaic 23 Direct Graft replacement 
of ascending aorta 
AF 8 months No 
2 No Yes CEP 21 Patch   32 months No 
3 No No CEP 21 Direct   49 months No 
4 No Yes CM 25 Patch  Transient AV block 48 months No 
5 No Yes CM 21 Patch   45 months No 
6 Yes Yes CM 21 Patch MVR, CABG (LAD) Reexploration for bleeding, 
AF, pneumonia 
6 months No 
7 Yes No CEP23 Patch Removal of vegetation 
from MV 
Gastrointestinal bleeding, 
prolonged respiratory support 
30 months No 
8 No No SJM17 Patch  AF, renal failure, 
pneumonia, tracheostomy 
Died on  
POD 66 
No 
AF: atrial fibrillation; AV: artioventricular; CABG: coronary artery bypass grafting; CEP: Carpentier-Edwards Pericardial tissue prosthesis; CM: 
CardoMedics mechanical prosthesis; LAD: left anterior descending artery; MV: mitral valve; MVR: mitral valve replacement; PVE: prosthetic valve 
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